Gallagher Cam

President, Interim CFO | President | Director

2 companies

Excellent

Trades Analyzed

12M Win Rate

94.9%

Avg 3M Return

+12.7%

Avg 12M Return

+48.2%

Gallagher Cam is a President, Interim CFO at IRD with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 45 sells.

Estimated insider holdings value: $12.7M based on current market prices.

Holdings by Company

IRDJan 6, 2026

Current Shares1.99M

Value$9.94M

Net Activity+172.9K

Bought: 172.9KSold: 0

ZNTLMay 31, 2024

Current Shares633.7K

Value$2.72M

Net Activity-515,936

Bought: 0Sold: 515.9K

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 18, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$62.64	$626,375.74	-0.6%	-60.2%	-60.5%
Jan 5, 2022	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$75.49	$754,861.09	-0.3%	-32.4%	-70.8%
Dec 15, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$74.03	$740,336.64	-0.3%	-46.1%	-75.6%
Dec 6, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$71.33	$713,300.00	-2.3%	-37.2%	-72.7%
Nov 15, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$75.36	$753,619.04	-0.8%	-35.2%	-70.3%
Nov 5, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$82.95	$829,490.94	-0.7%	-33.4%	-70.5%
Oct 1, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$66.15	$661,489.51	-0.5%	+23.2%	-67.7%
Sep 1, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$67.52	$675,229.30	-1.1%	+22.3%	-58.5%
Aug 2, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	10,000	$51.02	$510,197.85	-0.5%	+61.3%	-41.3%
Jul 7, 2021	ZNTL Zentalis Pharmaceuticals, Inc.	Director	Sell	18,370	$46.92	$861,856.11	-0.4%	+42.9%	-35.9%